Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations

Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations

Audrey Debaillon Vesque,1 Marie Decraecker,1 Jean-Frédéric Blanc1,2 1Department of Oncology, CHU Bordeaux, Hospital Haut Leveque, Pessac 33604 France; 2INSERM U1053, BaRITOn, University Victor Segalen, Bordeaux, FranceCorrespondence: Jean-Frédéric Blanc Em...

Full description

Bibliographic Details
Main Authors: Debaillon Vesque A, Decraecker M, Blanc JF
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
advanced hepatocellular carcinoma cabozantinib met alpha-fetoprotein (afp) tyrosine kinase inhibitor
Online Access:https://www.dovepress.com/profile-of-cabozantinib-for-the-treatment-of-hepatocellular-carcinoma--peer-reviewed-article-JHC

Internet

https://www.dovepress.com/profile-of-cabozantinib-for-the-treatment-of-hepatocellular-carcinoma--peer-reviewed-article-JHC

Similar Items